The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 727 KB) and Technical Notes (PDF, 1.1 MB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 1.4
Age-Adjusted SEER Incidence and U.S. Death Rates and 5-Year Relative Survival (Percent)
By Primary Cancer Site, Sex and Time Period
All Races
| Site | Incidencea (2014-2018) |
US Mortalityb (2014-2018) |
Survivalc (%) (2011-2017) |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Both Sexes | Males | Females | Both Sexes | Males | Females | Both Sexes | Males | Females | |
| All Sites | 450.5 | 489.2 | 425.6 | 155.5 | 185.5 | 133.5 | 67.7 | 66.4 | 68.9 |
| Oral Cavity & Pharynx: | 11.5 | 17.3 | 6.5 | 2.5 | 3.9 | 1.3 | 66.9 | 66.4 | 68.1 |
| Lip | 0.6 | 0.9 | 0.3 | 0.0 | 0.0 | 0.0 | 90.9 | 91.2 | 89.8 |
| Tongue | 3.6 | 5.4 | 2.0 | 0.7 | 1.0 | 0.4 | 68.1 | 68.4 | 67.1 |
| Salivary gland | 1.3 | 1.7 | 1.1 | 0.3 | 0.4 | 0.2 | 72.0 | 66.0 | 80.4 |
| Floor of mouth | 0.4 | 0.6 | 0.3 | 0.0 | 0.0 | 0.0 | 51.6 | 49.2 | 57.0 |
| Gum & other oral cavity | 1.6 | 1.9 | 1.3 | 0.4 | 0.5 | 0.3 | 61.3 | 58.7 | 64.5 |
| Nasopharynx | 0.6 | 0.9 | 0.3 | 0.2 | 0.3 | 0.1 | 61.9 | 60.0 | 66.7 |
| Tonsil | 2.1 | 3.6 | 0.7 | 0.3 | 0.4 | 0.1 | 75.5 | 76.0 | 72.9 |
| Oropharynx | 0.5 | 0.9 | 0.2 | 0.3 | 0.5 | 0.1 | 49.6 | 51.9 | 40.8 |
| Hypopharynx | 0.5 | 0.9 | 0.2 | 0.1 | 0.2 | 0.0 | 37.2 | 36.8 | 38.6 |
| Other oral cavity & pharynx | 0.2 | 0.4 | 0.1 | 0.4 | 0.7 | 0.2 | 50.6 | 52.7 | 42.5 |
| Digestive System: | 80.6 | 98.0 | 66.2 | 40.6 | 51.9 | 31.2 | 43.7 | 41.5 | 46.6 |
| Esophagus | 4.2 | 7.3 | 1.7 | 3.9 | 6.9 | 1.4 | 19.9 | 19.3 | 22.3 |
| Stomach | 7.2 | 9.7 | 5.3 | 3.0 | 4.0 | 2.2 | 32.4 | 29.1 | 37.4 |
| Small intestine | 2.4 | 2.8 | 2.1 | 0.4 | 0.5 | 0.3 | 68.3 | 68.0 | 68.6 |
| Colon & Rectum: | 37.8 | 43.2 | 33.3 | 13.7 | 16.3 | 11.5 | 64.7 | 64.3 | 65.3 |
| Colon | 26.5 | 29.1 | 24.3 | - | - | - | 63.6 | 63.3 | 63.8 |
| Rectum | 11.3 | 14.1 | 9.0 | - | - | - | 67.4 | 66.1 | 69.2 |
| Anus, anal canal & anorectum | 2.0 | 1.6 | 2.3 | 0.3 | 0.2 | 0.3 | 68.7 | 64.0 | 71.4 |
| Liver & intrahepatic bile duct | 9.0 | 13.8 | 4.9 | 6.6 | 9.7 | 4.0 | 20.3 | 20.1 | 20.9 |
| Gallbladder | 1.2 | 0.9 | 1.5 | 0.6 | 0.4 | 0.7 | 19.4 | 20.4 | 18.9 |
| Other biliary | 1.8 | 2.3 | 1.5 | 0.5 | 0.5 | 0.4 | 19.3 | 20.2 | 18.2 |
| Pancreas | 13.2 | 15.0 | 11.8 | 11.0 | 12.7 | 9.6 | 10.8 | 10.9 | 10.7 |
| Retroperitoneum | 0.4 | 0.4 | 0.4 | 0.1 | 0.1 | 0.1 | 55.1 | 52.9 | 56.9 |
| Peritoneum, omentum & mesentery | 0.5 | 0.1 | 0.8 | 0.3 | 0.1 | 0.4 | 32.8 | 39.1 | 32.4 |
| Other digestive system | 0.8 | 0.9 | 0.7 | 0.4 | 0.5 | 0.3 | 7.9 | 6.8 | 9.0 |
| Respiratory System: | 56.8 | 66.1 | 49.6 | 39.7 | 49.0 | 32.5 | 24.5 | 22.6 | 26.6 |
| Nose, nasal cavity & middle ear | 0.7 | 0.9 | 0.5 | 0.1 | 0.2 | 0.1 | 58.9 | 58.2 | 60.1 |
| Larynx | 2.8 | 4.9 | 1.1 | 0.9 | 1.7 | 0.4 | 60.7 | 61.4 | 57.8 |
| Lung & bronchus | 53.1 | 60.1 | 47.9 | 38.5 | 46.9 | 32.0 | 21.7 | 18.1 | 25.4 |
| Pleurad | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 22.0 | 18.5 | 26.5 |
| Trachea & other respiratory organs | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 56.2 | 54.8 | 59.9 |
| Bones & joints | 1.0 | 1.2 | 0.9 | 0.5 | 0.6 | 0.4 | 66.8 | 64.5 | 69.8 |
| Soft tissue (including heart) | 3.5 | 4.2 | 2.9 | 1.3 | 1.5 | 1.2 | 65.0 | 64.7 | 65.2 |
| Skin (excl. basal & squamous): | 24.8 | 32.1 | 19.4 | 3.3 | 5.1 | 1.9 | 92.5 | 90.8 | 94.8 |
| Melanoma of the skin | 22.8 | 29.3 | 18.0 | 2.3 | 3.4 | 1.4 | 93.3 | 91.7 | 95.3 |
| Other non-epithelial skin | 2.0 | 2.9 | 1.4 | 1.0 | 1.8 | 0.5 | 83.7 | 81.0 | 87.6 |
| Breast | 69.1 | 1.3 | 129.1 | 11.1 | 0.3 | 20.1 | 90.2 | 82.4 | 90.3 |
| Breast (in situ) | 17.1 | 0.1 | 32.5 | - | - | - | 100.0 | 100.0 | 100.0 |
| Female Genital System: | 27.4 | - | 51.6 | 8.2 | - | 14.9 | 70.2 | - | 70.2 |
| Cervix uteri | 3.8 | - | 7.5 | 1.2 | - | 2.2 | 66.3 | - | 66.3 |
| Corpus uteri | 14.5 | - | 27.2 | 1.3 | - | 2.4 | 82.7 | - | 82.7 |
| Uterus, NOS | 0.5 | - | 0.9 | 1.4 | - | 2.5 | 27.7 | - | 27.7 |
| Ovarye | 5.8 | - | 10.9 | 3.7 | - | 6.7 | 49.1 | - | 49.1 |
| Vagina | 0.4 | - | 0.7 | 0.1 | - | 0.2 | 48.7 | - | 48.7 |
| Vulva | 1.4 | - | 2.6 | 0.3 | - | 0.6 | 71.1 | - | 71.1 |
| Other female genital system | 1.0 | - | 1.8 | 0.2 | - | 0.4 | 50.2 | - | 50.2 |
| Male Genital System: | 54.4 | 118.4 | - | 8.1 | 19.5 | - | 97.1 | 97.1 | - |
| Prostate | 50.9 | 111.3 | - | 7.8 | 19.0 | - | 97.5 | 97.5 | - |
| Testis | 3.0 | 6.0 | - | 0.1 | 0.3 | - | 94.9 | 94.9 | - |
| Penis | 0.4 | 0.9 | - | 0.1 | 0.2 | - | 64.7 | 64.7 | - |
| Other male genital system | 0.1 | 0.3 | - | 0.0 | 0.0 | - | 85.1 | 85.1 | - |
| Urinary System: | 37.0 | 58.1 | 20.3 | 8.2 | 13.1 | 4.5 | 75.8 | 76.5 | 74.3 |
| Urinary bladder | 19.7 | 34.2 | 8.5 | 4.3 | 7.4 | 2.1 | 77.1 | 78.5 | 72.6 |
| Kidney & renal pelvis | 16.4 | 22.6 | 11.2 | 3.6 | 5.3 | 2.3 | 75.6 | 74.9 | 76.8 |
| Ureter | 0.5 | 0.8 | 0.4 | 0.1 | 0.1 | 0.1 | 47.7 | 49.3 | 45.5 |
| Other urinary system | 0.4 | 0.6 | 0.2 | 0.1 | 0.2 | 0.1 | 48.8 | 51.6 | 43.2 |
| Eye & Orbit | 0.8 | 1.0 | 0.8 | 0.1 | 0.1 | 0.1 | 83.6 | 83.6 | 83.7 |
| Brain & Nervous System:f | 6.4 | 7.6 | 5.4 | 4.4 | 5.4 | 3.6 | 32.6 | 31.2 | 34.3 |
| Brain | 6.0 | 7.1 | 5.0 | - | - | - | 29.4 | 28.4 | 30.6 |
| Cranial nerves & other nervous system | 0.4 | 0.4 | 0.4 | - | - | - | 79.5 | 77.5 | 81.5 |
| Endocrine System: | 16.3 | 8.9 | 23.5 | 0.8 | 0.8 | 0.8 | 96.7 | 93.0 | 97.9 |
| Thyroid | 15.5 | 8.0 | 22.8 | 0.5 | 0.5 | 0.5 | 98.3 | 96.0 | 98.9 |
| Other endocrine & thymus | 0.8 | 0.9 | 0.7 | 0.3 | 0.3 | 0.3 | 65.6 | 66.8 | 64.2 |
| Lymphoma: | 22.2 | 26.7 | 18.5 | 5.7 | 7.4 | 4.3 | 75.1 | 74.0 | 76.5 |
| Hodgkin lymphoma | 2.6 | 2.9 | 2.3 | 0.3 | 0.4 | 0.2 | 88.3 | 87.7 | 89.1 |
| Non-Hodgkin lymphoma | 19.6 | 23.7 | 16.2 | 5.4 | 7.0 | 4.1 | 73.2 | 72.0 | 74.6 |
| Myeloma | 7.1 | 8.8 | 5.7 | 3.2 | 4.1 | 2.6 | 55.6 | 55.7 | 55.5 |
| Leukemia: | 14.3 | 18.3 | 11.1 | 6.3 | 8.4 | 4.7 | 65.0 | 65.7 | 64.0 |
| Lymphocytic: | 7.1 | 9.3 | 5.2 | 1.7 | 2.4 | 1.2 | 82.5 | 82.7 | 82.3 |
| Acute lymphocytic | 1.8 | 2.0 | 1.5 | 0.4 | 0.5 | 0.4 | 69.9 | 69.5 | 70.3 |
| Chronic lymphocytic | 4.9 | 6.7 | 3.5 | 1.1 | 1.6 | 0.8 | 87.2 | 86.8 | 87.8 |
| Other lymphocytic | 0.4 | 0.6 | 0.2 | 0.1 | 0.2 | 0.1 | 84.3 | 87.5 | 73.8 |
| Myeloid & Monocytic: | 6.5 | 8.1 | 5.3 | 3.4 | 4.4 | 2.6 | 43.5 | 43.3 | 43.8 |
| Acute myeloid | 4.3 | 5.2 | 3.6 | 2.8 | 3.6 | 2.2 | 29.5 | 28.5 | 30.7 |
| Chronic myeloid | 1.9 | 2.5 | 1.5 | 0.3 | 0.4 | 0.2 | 70.6 | 69.5 | 72.2 |
| Acute monocytic | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 24.8 | 24.0 | 25.6 |
| Other myeloid & monocytic | 0.1 | 0.2 | 0.1 | 0.3 | 0.4 | 0.2 | 38.4 | 39.6 | 36.2 |
| Other leukemia: | 0.7 | 0.9 | 0.6 | 1.2 | 1.6 | 0.9 | 50.9 | 50.2 | 51.7 |
| Other acute leukemia | 0.2 | 0.3 | 0.2 | 0.4 | 0.5 | 0.3 | 26.9 | 27.9 | 25.7 |
| Aleukemic, subleukemic & NOS | 0.5 | 0.6 | 0.4 | 0.8 | 1.1 | 0.6 | 60.2 | 59.5 | 61.0 |
| Kaposi Sarcomag | 0.5 | 0.9 | 0.1 | - | - | - | 73.9 | 73.3 | 80.2 |
| Mesotheliomag | 0.8 | 1.4 | 0.4 | - | - | - | 11.5 | 9.1 | 18.2 |
| Ill-defined & unspecified | 15.9 | 19.0 | 13.6 | 11.5 | 14.4 | 9.3 | 40.8 | 40.8 | 40.8 |
Footnotes:
Note: Incidence and death rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).
a SEER 21 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey, Georgia excluding ATL/RG, Idaho, New York and Massachusetts).
b US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention.
c SEER 18 areas. Based on follow-up of patients into 2018. Expected survival rates are derived from life tables by socio-economic status, geography and race developed by the SEER program.
d Mesotheliomas of the Pleura are included in the separate group Mesothelioma for incidence but are included in the Pleura grouping for mortality.
e Ovary excludes borderline cases or histologies 8442, 8451, 8462, 8472, and 8473.
f Due to coding changes, Brain & Nervous System mortality are no longer shown separately.
g Rate not shown for mortality. Category did not exist in mortality coding until 1999.
- Statistic could not be calculated due to less than 16 cases in the time interval.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.